01:10 PM EDT, 03/18/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) said Monday it appointed Patrick Horn as chief medical officer, effective immediately.

Iain Fraser had been interim chief medical officer, and he will continue as senior vice president of early development, Fulcrum Therapeutics ( FULC ) said.

Horn most recently served as chief medical officer at HemoShear Therapeutics.

The company's shares fell 8.1% in recent trading.

Price: 10.36, Change: -1.00, Percent Change: -8.80